Download presentation
Presentation is loading. Please wait.
Published byNoah Floyd Modified over 9 years ago
1
EURAMOS 1 A randomised trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy Jeremy Whelan for the EURAMOS 1 Trial Management Group, 4 th November 2006
2
EURAMOS EURAMOS is the European and American Osteosarcoma Study Group. The study was founded in 2001. Children’s Oncology Group Cooperative Osteosarcoma Study Group European Osteosarcoma Intergroup Scandinavian Sarcoma Group
3
EURAMOS Established Oct 2001 Aim to improve survival from OS Objectives to carry out large international randomised trials to facilitate biological research to seek new therapeutic approaches to develop common understanding and methodologies for staging, pathology etc.
4
EURAMOS 1 Co-sponsored MRC in Europe COG for North America Co-ordinating Data Centre MRC Clinical Trials Unit
5
Trial Design
6
Key registration criteria High grade OS of extremity or axial skeleton Resectable disease Fit for treatment
7
Trial Design Key randomisation criteria Adequate pre-operative chemotherapy Macroscopically complete resection of primary tumour Complete removal of all metastases or complete removal planned and feasible Histological response assessment
8
Trial Design Primary Objectives Addition of IE to post-op MAP chemotherapy improves EFS for poor responders Addition of ifn to post-op MAP chemotherapy improves EFS for good responders
9
Trial Design Secondary Objectives Additional treatment improves OS, short and long term toxicity and quality of life Additional treatment improves EFS in localised disease Investigate biological and clinical correlated to histological response and outcome International cooperation in trials Examine outcome of the entire cohort of patients
10
Trial Design- additional studies Quality of Life Biology Studies
11
EURAMOS participants
12
Progress: open and recruiting RegisteredRandomised USA11140 Germany8742 UK4217 Netherlands145 Norway114 Canada102 Belgium95 Switzerland85 Sweden53 Demark20 Hungary10 Australia20 Total302123
13
Progress: almost ready Austria Finland
14
Progress: requests to join Czech Republic Ireland Poland Israel
15
Accrual 302 Registered
16
Accrual 302 Registered
17
Accrual 123 Randomised
18
EURAMOS 1 Chief Investigators Mark Bernstein (TMG Chair) Neyssa Marina (COG) Stephan Bielack (COSS) Jeremy Whelan (EOI) Sigbjorn Smeland (SSG) Website www.euramos.org
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.